Evidence map›Paper›PMID 29988126›Full record

ArticleNature medicine2018

Reducing protein oxidation reverses lung fibrosis.

Vikas Anathy, Karolyn G Lahue, David G Chapman, Shi B Chia, Dylan T Casey, Reem Aboushousha, Jos L J van der Velden, Evan Elko, Sidra M Hoffman, David H McMillan and 21 more

Abstract read
In one paragraph

Article in Nature medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 83 papers.

0numbers the graph read from it
0cells of the map it votes in
83citing papers in PubMed
9.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

83 citing papers in PubMed, 119 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. SCPEP1Frontiers in immunology · 2025
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Endothelial HRedox biology · 2024
    Article
  20. Article

23 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors at 6 institutions in 2 countries.

Vikas AnathyDepartment of Pathology and Laboratory Medicine, University of Vermont, Burlington, VT, USA.
Karolyn G LahueDepartment of Pathology and Laboratory Medicine, University of Vermont, Burlington, VT, USA.
David G ChapmanDepartment of Medicine, University of Vermont, Burlington, VT, USA.ORCID http://orcid.org/0000-0002-8211-1817
Shi B ChiaDepartment of Pathology and Laboratory Medicine, University of Vermont, Burlington, VT, USA.
Dylan T CaseyDepartment of Pathology and Laboratory Medicine, University of Vermont, Burlington, VT, USA.
Reem AboushoushaDepartment of Pathology and Laboratory Medicine, University of Vermont, Burlington, VT, USA.
Jos L J van der VeldenDepartment of Pathology and Laboratory Medicine, University of Vermont, Burlington, VT, USA.
Evan ElkoDepartment of Pathology and Laboratory Medicine, University of Vermont, Burlington, VT, USA.
Sidra M HoffmanDepartment of Pathology and Laboratory Medicine, University of Vermont, Burlington, VT, USA.
David H McMillanDepartment of Pathology and Laboratory Medicine, University of Vermont, Burlington, VT, USA.
Jane T JonesDepartment of Pathology and Laboratory Medicine, University of Vermont, Burlington, VT, USA.
James D NolinDepartment of Pathology and Laboratory Medicine, University of Vermont, Burlington, VT, USA.
Sarah AbdallaDepartment of Pathology and Laboratory Medicine, University of Vermont, Burlington, VT, USA.
Robert SchneiderDepartment of Pathology and Laboratory Medicine, University of Vermont, Burlington, VT, USA.
David J SewardDepartment of Pathology and Laboratory Medicine, University of Vermont, Burlington, VT, USA.
Elle C RobersonHonors College, University of Vermont, Burlington, VT, USA.
Matthew D LiptakDepartment of Chemistry, University of Vermont, Burlington, VT, USA.
Morgan E CousinsDepartment of Chemistry, University of Vermont, Burlington, VT, USA.
Kelly J ButnorDepartment of Pathology and Laboratory Medicine, University of Vermont, Burlington, VT, USA.
Douglas J TaatjesDepartment of Pathology and Laboratory Medicine, University of Vermont, Burlington, VT, USA.
Ralph C BuddDepartment of Medicine, University of Vermont, Burlington, VT, USA.
Charles G IrvinDepartment of Medicine, University of Vermont, Burlington, VT, USA.
Ye-Shih HoInstitute of Environmental Health Sciences, Wayne State University, Detroit, MI, USA.
Razq HakemDepartment of Medical Biophysics and Immunology, University of Toronto, and the Ontario Cancer Institute/University Health Network, Toronto, Ontario, Canada.
Kevin K BrownDepartment of Medicine, Pulmonary, Critical Care and Sleep Section, National Jewish Health and the University of Colorado, Denver, CO, USA.
Reiko MatsuiDepartment of Medicine, Boston University, Boston, MA, USA.
Markus M BachschmidDepartment of Medicine, Boston University, Boston, MA, USA.
Jose L GomezDepartment of Medicine, Yale School of Medicine, New Haven, CT, USA.
Naftali KaminskiDepartment of Medicine, Yale School of Medicine, New Haven, CT, USA.ORCID http://orcid.org/0000-0001-5917-4601
Albert van der VlietDepartment of Pathology and Laboratory Medicine, University of Vermont, Burlington, VT, USA.
Yvonne M W Janssen-HeiningerDepartment of Pathology and Laboratory Medicine, University of Vermont, Burlington, VT, USA. yvonne.janssen@uvm.edu.
University of Vermont · USBoston University · USYale University · USNational Jewish Health · USOntario Institute for Cancer Research · CAWayne State University · US

Funding

Project-005UL1TR001430 · NCATS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI BAIR-MERRITT, MEGAN H, CENTER, DAVID M. · 2015 to 2024
$52.3M
VERMONT IMMUNOBIOLOIGY/ INFECTIOUS DISEASES CENTERP20RR021905 · NCRR · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI BUDD, RALPH C · 2006 to 2011
$14.5M
Lung Genomics Research ConsortiumRC2HL101715 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI GERACI, MARK W, KAMINSKI, NAFTALI · 2009 to 2010
$11.4M
Vermont Immunology/Infectious Diseases CenterP30GM118228 · NIGMS · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI BUDD, RALPH C · 2016 to 2021
$6.8M
S-glutathionylation chemistry in fibrotic lung remodelingR35HL135828 · NHLBI · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI JANSSEN-HEININGER, YVONNE M. W. · 2017 to 2023
$6.5M
Multidisciplinary Training in Lung BiologyT32HL076122 · NHLBI · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI IRVIN, CHARLES G, POYNTER, MATTHEW E · 2004 to 2023
$6.1M
REGULATION OF NFKB IN LUNG EPITHELIUM BY ROS/RNSR01HL060014 · NHLBI · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI JANSSEN-HEININGER, YVONNE M. W. · 1999 to 2016
$5.9M
Dual Oxidase in Airway Epithelial Repair and RemodelingR01HL085646 · NHLBI · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI VAN DER VLIET, ALBERT · 2008 to 2020
$4.7M
Redox-based Fas Signaling in Allergic Airway DiseaseR01HL079331 · NHLBI · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI JANSSEN-HEININGER, YVONNE M. W. · 2005 to 2016
$4.2M
Translational Research in Lung Biology and DiseaseP30GM103532 · NIGMS · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI IRVIN, CHARLES G · 2012 to 2016
$3.7M
Endoplasmic Reticulum Stress Signaling in Allergen-induced Airway RemodelingR01HL122383 · NHLBI · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI ANATHY, VIKAS · 2015 to 2023
$3.5M
Epithelial JNK-TGFb1 Signaling Axis in Airway RemodelingR01HL085464 · NHLBI · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI JANSSEN-HEININGER, YVONNE M. W. · 2008 to 2016
$3.0M
NCATS NIH HHS UL1 TR001430NCI NIH HHS R01 CA219156NCRR NIH HHS P20 RR021905NCRR NIH HHS S10 RR019246NHLBI NIH HHS K01 HL125474NHLBI NIH HHS R01 HL060014NHLBI NIH HHS R01 HL079331NHLBI NIH HHS R01 HL085464NHLBI NIH HHS R01 HL085646NHLBI NIH HHS R01 HL122383NHLBI NIH HHS R01 HL133013NHLBI NIH HHS R01 HL137268NHLBI NIH HHS R01 HL138708NHLBI NIH HHS R03 HL095404NHLBI NIH HHS R35 HL135828NHLBI NIH HHS RC2 HL101715NHLBI NIH HHS T32 HL076122NHLBI NIH HHS U01 HL108642NIA NIH HHS R03 AG051857NIDDK NIH HHS R01 DK103750NIGMS NIH HHS P30 GM103532NIGMS NIH HHS P30 GM118228
6 · The paper itself

Abstract

Idiopathic pulmonary fibrosis is characterized by excessive deposition of collagen in the lung, leading to chronically impaired gas exchange and death

Indexed as

AnimalsFemaleGlutaredoxinsGlutathioneIdiopathic Pulmonary FibrosisLungMice, Inbred C57BLMice, TransgenicOxidation-ReductionProteinsGlutaredoxinsGlutathioneProteins

Identifiers

PMID29988126
PMCPMC6204256
OpenAlexW2871400816

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.